{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:26:57Z","timestamp":1792193217512,"version":"4.4.0"},"reference-count":193,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Extrahepatic cholangiocarcinoma (eCCA) is a highly malignant tumor with a propensity for metastasis, reflected in its estimated 5-year survival rate of 11%. Metastasis greatly impairs the effectiveness of cancer therapies and increases cancer-related deaths. Therefore, gaining an understanding of the complex metastatic process is essential for development of effective treatments. Metastasis progression involves remodeling of the tumor microenvironment (TME) and the formation of premetastatic niches (PMNs), facilitating the migration and survival of tumor cells from the primary site to distant locations. As the eCCA progresses, immune cells, fibroblasts, and endothelial cells in the TME are gradually converted to a tumor-supportive phenotype, coordinating tumor metastasis through intercellular interactions. Recent studies have confirmed that bile, a body fluid in close contact with eCCA, is also involved in the formation of supportive TME and tumor metastasis. On the contrary, primary tumors construct PMNs conducive to cancer cell colonization in distant organs before metastatic tumor formation through paracrine effects. This review aimed to summarize the mechanisms by which TME and PMNs drive eCCA metastasis, current treatment strategies for metastatic eCCA, and prospects for future research.<\/jats:p>","DOI":"10.1097\/js9.0000000000003852","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:00:20Z","timestamp":1762556420000},"page":"4452-4466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Metastatic microenvironment of extrahepatic cholangiocarcinoma"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-7287","authenticated-orcid":false,"given":"Ruiqian","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wei","sequence":"additional","affiliation":[{"name":"Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[{"name":"Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"Department of Pediatric Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2775-5863","authenticated-orcid":false,"given":"Chengzhan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"R1-20260512","first-page":"16\u201346","article-title":"British society of gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma","volume":"73","author":"Rushbrook","year":"2023","journal-title":"Gut"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"95\u2013103","DOI":"10.1016\/j.jhep.2019.09.007","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"72","author":"Clements","year":"2020","journal-title":"J Hepatol"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"557\u201388","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"1003\u201310","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nature Genet"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"1116\u201335","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-Genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discovery"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"4154\u201361","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-022-30708-7","article-title":"The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"R8-20260512","first-page":"2631\u201342","article-title":"Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma","volume":"12","author":"Zheng","year":"2021","journal-title":"J Gastrointestinal Oncol"},{"key":"R9-20260512","first-page":"1095\u2013105","article-title":"Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles","volume":"25","author":"Simbolo","year":"2021","journal-title":"Expert Opin Therapeutic Targets"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"e2400206","DOI":"10.1200\/PO.24.00206","article-title":"Extrahepatic cholangiocarcinoma: genomic variables associated with anatomic location and outcome","volume":"8","author":"Preston","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"908\u201318","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"378\u201388,88.e1\u20134","DOI":"10.1053\/j.gastro.2011.03.044","article-title":"A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression","volume":"141","author":"Yang","year":"2011","journal-title":"Gastroenterol"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"1564\u201378","DOI":"10.1053\/gast.1996.v110.pm8613064","article-title":"Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver","volume":"110","author":"Rahner","year":"1996","journal-title":"Gastroenterol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"205\u201316","DOI":"10.1002\/hep.510290115","article-title":"Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis","volume":"29","author":"Kawaguchi","year":"1999","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R16-20260512","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"127\u201340","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"100737","DOI":"10.1016\/j.aohep.2022.100737","article-title":"Clinical treatment of cholangiocarcinoma: an updated comprehensive review","volume":"27","author":"Elvevi","year":"2022","journal-title":"Ann Hepatol"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"1109\u201321","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"1273\u201381","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"New Engl J Med"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"694\u2013704","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"1564\u201379","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"359\u201376","DOI":"10.1038\/s41568-018-0006-7","article-title":"A history of exploring cancer in context","volume":"18","author":"Maman","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"108522","DOI":"10.1016\/j.pharmthera.2023.108522","article-title":"Cancer metastasis: molecular mechanisms and clinical perspectives","volume":"250","author":"Khan","year":"2023","journal-title":"Pharmacol Ther"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"302\u201317","DOI":"10.1038\/nrc.2017.6","article-title":"Pre-metastatic niches: organ-specific homes for metastases","volume":"17","author":"Peinado","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"2131\u201347","DOI":"10.1097\/JS9.0000000000002206","article-title":"Current advance in comprehensive management of hilar cholangiocarcinoma and navigation in surgery: non-systematic reviews","volume":"111","author":"Luo","year":"2025","journal-title":"Int J Surg (London, England)"},{"key":"R27-20260512","first-page":"3543\u201360","article-title":"Efficacy and safety of preoperative biliary drainage in patients with Hilar Cholangiocarcinoma: a systematic review and meta-analysis","volume":"111","author":"Chen","year":"2025","journal-title":"Int J Surg (London, England)"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"470\u201386","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"916\u201322","DOI":"10.1001\/jamasurg.2016.1769","article-title":"Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an italian multicenter analysis","volume":"151","author":"Giuliante","year":"2016","journal-title":"JAMA Surg"},{"key":"R30-20260512","first-page":"4306\u201317","article-title":"Rational extent of regional lymphadenectomy and the prognostic impact of the number of positive lymph nodes for perihilar cholangiocarcinoma","volume":"30","author":"Sakata","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"1934\u201340","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R32-20260512","first-page":"7719\u201329","article-title":"Surgery for bismuth-corlette type 4 perihilar cholangiocarcinoma: results from a western multicenter collaborative group","volume":"28","author":"Ruzzenente","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"11\u201320","DOI":"10.1016\/j.surg.2023.03.013","article-title":"Prognostic impact of proximal ductal margin status in perihilar cholangiocarcinoma according to the presence or absence of lymph node metastasis","volume":"174","author":"Hosokawa","year":"2023","journal-title":"Surgery"},{"key":"R35-20260512","first-page":"1335\u201348","article-title":"Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"717\u201325","DOI":"10.1016\/j.dld.2016.03.019","article-title":"Clinical prognostic significance of regional and extended lymphadenectomy for biliary cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis","volume":"48","author":"Gu","year":"2016","journal-title":"Dig Liver Dis"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"S1107","DOI":"10.1245\/s10434-015-4723-9","article-title":"Lymph node micrometastases are associated with worse survival in patients with otherwise node-negative hilar cholangiocarcinoma","volume":"22 Suppl 3","author":"Mantel","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.gie.2016.02.045","article-title":"Impact of EUS-FNA for preoperative para-aortic lymph node staging in patients with pancreatobiliary cancer","volume":"84","author":"Kurita","year":"2016","journal-title":"Gastrointestinal Endosc"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"5006\u201314","DOI":"10.1002\/cam4.1772","article-title":"Pattern of distant metastases in primary extrahepatic bile-duct cancer: a SEER-based study","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"290\u201396","DOI":"10.1016\/j.surg.2019.04.029","article-title":"Occult synchronous liver metastasis from perihilar cholangiocarcinoma","volume":"166","author":"Ohiwa","year":"2019","journal-title":"Surgery"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41420-024-02079-z","article-title":"Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"10","author":"Sun","year":"2024","journal-title":"Cell Death Discovery"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"569\u201374","DOI":"10.1055\/s-2002-33228","article-title":"Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer","volume":"34","author":"Fujimura","year":"2002","journal-title":"Endoscopy"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"407\u201315","DOI":"10.1148\/radiol.2532082272","article-title":"Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer","volume":"253","author":"Kim","year":"2009","journal-title":"Radiology"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"109118","DOI":"10.1016\/j.ejrad.2020.109118","article-title":"Imaging features of bone metastases from cholangiocarcinoma","volume":"129","author":"Thammaroj","year":"2020","journal-title":"Eur J Radiol"},{"key":"R45-20260512","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12957-019-1656-y","article-title":"A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction","volume":"17","author":"Wang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"374\u2013403","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"R47-20260512","first-page":"75\u201385","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73 Suppl 1","author":"Fabris","year":"2021","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12967-022-03424-5","article-title":"Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma","volume":"20","author":"Xu","year":"2022","journal-title":"J Transl Med"},{"key":"R49-20260512","doi-asserted-by":"crossref","first-page":"450\u201365","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"R51-20260512","doi-asserted-by":"crossref","first-page":"1303\u201310","DOI":"10.1084\/jem.20062129","article-title":"Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression","volume":"204","author":"Bopp","year":"2007","journal-title":"J Exp Med"},{"key":"R52-20260512","doi-asserted-by":"crossref","first-page":"2665\u201374","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br J Cancer"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"171\u201380","DOI":"10.1038\/bjc.2017.401","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Kitano","year":"2018","journal-title":"Br J Cancer"},{"key":"R54-20260512","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12876-025-03829-8","article-title":"Single-cell transcriptomic analysis reveals prognosis-related stromal signatures that potentiate stratification of patients with extrahepatic cholangiocarcinoma","volume":"25","author":"Ni","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"162\u201371","DOI":"10.4143\/crt.2020.704","article-title":"Spatial distribution and prognostic implications of tumor-infiltrating FoxP3- CD4+ T cells in biliary tract cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Cancer Res Treat"},{"key":"R56-20260512","doi-asserted-by":"crossref","first-page":"645\u201352","DOI":"10.21873\/anticanres.16201","article-title":"Epithelial-Mesenchymal transition phenotype and peritumoral immune cell infiltration in advanced biliary tract cancer","volume":"43","author":"Oh","year":"2023","journal-title":"Anticancer Res"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"361\u201374","DOI":"10.1016\/j.devcel.2019.04.010","article-title":"Epithelial-mesenchymal plasticity in cancer progression and metastasis","volume":"49","author":"Lu","year":"2019","journal-title":"Dev Cell"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"110091","DOI":"10.1016\/j.intimp.2023.110091","article-title":"MUC1 induces the accumulation of Foxp3(+) Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR\/PI3K\/Akt signaling pathway","volume":"118","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1002\/iid3.727","article-title":"Forkhead box M1 recruits FoxP3(+) Treg cells to induce immune escape in hilar cholangiocarcinoma","volume":"10","author":"Ma","year":"2022","journal-title":"Immun Inflammation Dis"},{"key":"R60-20260512","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-025-01716-z","article-title":"Deciphering cholangiocarcinoma heterogeneity and specific progenitor cell niche of extrahepatic cholangiocarcinoma at single-cell resolution","volume":"18","author":"Liu","year":"2025","journal-title":"J Hematol Oncol"},{"key":"R61-20260512","doi-asserted-by":"crossref","first-page":"33\u201345","DOI":"10.1038\/s41423-021-00742-4","article-title":"Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy","volume":"19","author":"Huppert","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1016\/j.celrep.2020.03.007","article-title":"Lymph node stromal cells generate antigen-specific regulatory T cells and control autoreactive T and B cell responses","volume":"30","author":"Nadafi","year":"2020","journal-title":"Cell Rep"},{"key":"R63-20260512","doi-asserted-by":"crossref","first-page":"215.14\u2013215.14","DOI":"10.4049\/jimmunol.198.Supp.215.14","article-title":"Regulatory T cells exhibit distinct lymph node homing and trafficking kinetics as compared to conventional CD4+ T cells","volume":"198","author":"Tong","year":"2017","journal-title":"J Immunol"},{"key":"R64-20260512","doi-asserted-by":"crossref","first-page":"eaba0759","DOI":"10.1126\/sciimmunol.aba0759","article-title":"Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"R65-20260512","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","article-title":"Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche","volume":"166","author":"Clever","year":"2016","journal-title":"Cell"},{"key":"R66-20260512","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduction Targeted Ther"},{"key":"R67-20260512","doi-asserted-by":"crossref","first-page":"1148\u201356","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat Immunol"},{"key":"R68-20260512","doi-asserted-by":"crossref","first-page":"830350","DOI":"10.3389\/fonc.2022.830350","article-title":"Inflammasome-associated gastric tumorigenesis is independent of the NLRP3 pattern recognition receptor","volume":"12","author":"West","year":"2022","journal-title":"Front Oncol"},{"key":"R69-20260512","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R70-20260512","doi-asserted-by":"crossref","first-page":"91\u201398","DOI":"10.1002\/jso.24249","article-title":"Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma","volume":"114","author":"Atanasov","year":"2016","journal-title":"J Surg Oncol"},{"key":"R71-20260512","doi-asserted-by":"crossref","first-page":"183\u201390","DOI":"10.21873\/anticanres.11304","article-title":"Prognostic impact of CD163+ macrophages in tumor stroma and CD8+ T-cells in cancer cell nests in invasive extrahepatic bile duct cancer","volume":"37","author":"Miura","year":"2017","journal-title":"Anticancer Res"},{"key":"R72-20260512","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-021-02235-8","article-title":"Macrophages-aPKC(\u0269)-CCL5 feedback loop modulates the progression and chemoresistance in cholangiocarcinoma","volume":"41","author":"Yang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"R73-20260512","doi-asserted-by":"crossref","first-page":"102\u201315","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"J Hepatol"},{"key":"R74-20260512","doi-asserted-by":"crossref","first-page":"241\u201355","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev"},{"key":"R75-20260512","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cmet.2019.07.015","article-title":"Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer","volume":"30","author":"Bieniasz-Krzywiec","year":"2019","journal-title":"Cell Metab"},{"key":"R76-20260512","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-024-02086-9","article-title":"Targeting circ-0034880-enriched tumor extracellular vesicles to impede SPP1(high)CD206(+) pro-tumor macrophages mediated pre-metastatic niche formation in colorectal cancer liver metastasis","volume":"23","author":"Zhou","year":"2024","journal-title":"Mol Cancer"},{"key":"R77-20260512","doi-asserted-by":"crossref","first-page":"490\u2013504","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"van Vlerken-ysla","year":"2023","journal-title":"Cancer Cell"},{"key":"R78-20260512","doi-asserted-by":"crossref","first-page":"391\u2013411","DOI":"10.1007\/s10555-020-09947-x","article-title":"Role of myeloid-derived suppressor cells in metastasis","volume":"40","author":"Cole","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"R79-20260512","doi-asserted-by":"crossref","first-page":"183\u201394","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"R80-20260512","doi-asserted-by":"crossref","first-page":"938289","DOI":"10.3389\/fcell.2022.938289","article-title":"Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications","volume":"10","author":"Yan","year":"2022","journal-title":"Front Cell Develop Biol"},{"key":"R81-20260512","doi-asserted-by":"crossref","first-page":"e001946","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J ImmunoTher Cancer"},{"key":"R82-20260512","doi-asserted-by":"crossref","first-page":"99\u2013115","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R83-20260512","doi-asserted-by":"crossref","first-page":"941\u201358","DOI":"10.1097\/HEP.0000000000000206","article-title":"Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma","volume":"79","author":"Cantallops Vil\u00e0","year":"2024","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R84-20260512","doi-asserted-by":"crossref","first-page":"20644","DOI":"10.1038\/s41598-025-05645-2","article-title":"Activated cancer-associated fibroblasts correlate with poor survival and decreased lymphocyte infiltration in infiltrative type distal cholangiocarcinoma","volume":"15","author":"Lim","year":"2025","journal-title":"Sci Rep"},{"key":"R85-20260512","doi-asserted-by":"crossref","first-page":"2001\u201311","DOI":"10.1002\/hep.26585","article-title":"Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor","volume":"58","author":"Clap\u00e9ron","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R86-20260512","doi-asserted-by":"crossref","first-page":"325\u201332","DOI":"10.1016\/j.jhep.2014.03.033","article-title":"EGF\/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition","volume":"61","author":"Clap\u00e9ron","year":"2014","journal-title":"J Hepatol"},{"key":"R87-20260512","doi-asserted-by":"crossref","first-page":"153\u201386","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Ann Rev Pathol"},{"key":"R88-20260512","doi-asserted-by":"crossref","first-page":"554\u201367","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R89-20260512","doi-asserted-by":"crossref","first-page":"700\u201309","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro","year":"2019","journal-title":"J Hepatol"},{"key":"R90-20260512","first-page":"1118\u201330","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J Hepatol"},{"key":"R91-20260512","doi-asserted-by":"crossref","first-page":"1019\u201327","DOI":"10.1097\/01.MP.0000086860.65672.73","article-title":"Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"16","author":"Aishima","year":"2003","journal-title":"Mod Pathol"},{"key":"R92-20260512","first-page":"397\u2013410","article-title":"The role of lymphangiogenesis and angiogenesis in tumor metastasis","volume":"39","author":"Paduch","year":"2016","journal-title":"Cellular Oncology (Dordrecht, Netherlands)"},{"key":"R93-20260512","doi-asserted-by":"crossref","first-page":"63\u201378","DOI":"10.1016\/j.addr.2020.12.005","article-title":"Development and aging of the lymphatic vascular system","volume":"169","author":"Gonz\u00e1lez-Loyola","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"R94-20260512","doi-asserted-by":"crossref","first-page":"1837\u201379","DOI":"10.1152\/physrev.00039.2021","article-title":"Lymphatic vessels in cancer","volume":"102","author":"Dieterich","year":"2022","journal-title":"Physiol Rev"},{"key":"R95-20260512","doi-asserted-by":"crossref","first-page":"3423\u201331","DOI":"10.1182\/blood-2005-04-1388","article-title":"Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways","volume":"106","author":"Salameh","year":"2005","journal-title":"Blood"},{"key":"R97-20260512","doi-asserted-by":"crossref","first-page":"256\u201364","DOI":"10.1038\/modpathol.3800985","article-title":"Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma","volume":"21","author":"Aishima","year":"2008","journal-title":"Mod Pathol"},{"key":"R98-20260512","first-page":"9029\u201340","article-title":"Receptor-interacting protein kinase 1 promotes cholangiocarcinoma proliferation and lymphangiogenesis through the activation protein 1 pathway","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R99-20260512","doi-asserted-by":"crossref","first-page":"460\u201376","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"R100-20260512","doi-asserted-by":"crossref","first-page":"1350\u201363","DOI":"10.1136\/gutjnl-2023-331715","article-title":"Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment","volume":"73","author":"Shi","year":"2024","journal-title":"Gut"},{"key":"R101-20260512","doi-asserted-by":"crossref","first-page":"369\u201389","DOI":"10.14336\/AD.2023.0420","article-title":"Cancer-associated fibroblasts promote lymphatic metastasis in cholangiocarcinoma via the PDGF-BB\/PDGFR-\u03b2 mediated paracrine signaling network","volume":"15","author":"Yan","year":"2024","journal-title":"Aging Disease"},{"key":"R102-20260512","doi-asserted-by":"crossref","first-page":"908\u201324","DOI":"10.1007\/s00535-023-02012-8","article-title":"Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma","volume":"58","author":"Peng","year":"2023","journal-title":"J Gastroenterol"},{"key":"R103-20260512","doi-asserted-by":"crossref","first-page":"1377\u201386","DOI":"10.1016\/j.jhep.2021.07.016","article-title":"Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma","volume":"75","author":"Carpino","year":"2021","journal-title":"J Hepatol"},{"key":"R104-20260512","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/cells10113093","article-title":"Tumor lymphatic interactions induce CXCR2-CXCL5 axis and alter cellular metabolism and lymphangiogenic pathways to promote cholangiocarcinoma","volume":"10","author":"Roy","year":"2021","journal-title":"Cells"},{"key":"R105-20260512","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.3390\/ijms232113470","article-title":"Tumor-associated lymphatics upregulate MHC-II to Suppress tumor-infiltrating lymphocytes","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R106-20260512","doi-asserted-by":"crossref","first-page":"1767\u201379","DOI":"10.4049\/jimmunol.0802167","article-title":"Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1\/ICAM-1-dependent mechanism","volume":"183","author":"Podgrabinska","year":"2009","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"R107-20260512","first-page":"70\u201382","article-title":"Tumor-derived nanoseeds condition the soil for metastatic organotropism","volume":"93","author":"Hu","year":"2023","journal-title":"Semi Cancer Biol"},{"key":"R108-20260512","doi-asserted-by":"crossref","first-page":"327\u201336","DOI":"10.1016\/j.jconrel.2022.11.050","article-title":"Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche","volume":"353","author":"Luo","year":"2023","journal-title":"J Control Release"},{"key":"R109-20260512","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00018-022-04500-1","article-title":"BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci Cmls"},{"key":"R110-20260512","first-page":"582\u201395","article-title":"Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p\/SOX9 axis through PI3K\/AKT pathway","volume":"30","author":"Ni","year":"2023","journal-title":"Cancer Genet Ther"},{"key":"R111-20260512","doi-asserted-by":"crossref","first-page":"424\u201338","DOI":"10.1053\/j.gastro.2022.11.025","article-title":"PTEN deficiency facilitates exosome secretion and metastasis in cholangiocarcinoma by impairing TFEB-mediated lysosome biogenesis","volume":"164","author":"Jiang","year":"2023","journal-title":"Gastroenterol"},{"key":"R112-20260512","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12951-024-02459-8","article-title":"Circulating tumor cell-derived exosome-transmitted long non-coding RNA TTN-AS1 can promote the proliferation and migration of cholangiocarcinoma cells","volume":"22","author":"Zhou","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"R113-20260512","doi-asserted-by":"crossref","first-page":"24900","DOI":"10.3402\/jev.v4.24900","article-title":"Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth","volume":"4","author":"Haga","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R114-20260512","doi-asserted-by":"crossref","first-page":"982\u201399","DOI":"10.1002\/hep.32387","article-title":"Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression","volume":"76","author":"Luo","year":"2022","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R115-20260512","doi-asserted-by":"crossref","first-page":"307\u201322","DOI":"10.1097\/HEP.0000000000000437","article-title":"Bile exosomal miR-182\/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation","volume":"79","author":"Shu","year":"2024","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R116-20260512","doi-asserted-by":"crossref","first-page":"370\u201388","DOI":"10.1111\/liv.15773","article-title":"Exosome-derived miR-182-5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK\/SEMA5a\/PI3K pathway","volume":"44","author":"Wang","year":"2024","journal-title":"Liver Int"},{"key":"R117-20260512","first-page":"4571\u201387","article-title":"Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner","volume":"19","author":"Jiang","year":"2023","journal-title":"Int J Bio Sci"},{"key":"R118-20260512","doi-asserted-by":"crossref","first-page":"1419\u201335","DOI":"10.1002\/hep.31493","article-title":"A circular RNA, cholangiocarcinoma-associated circular RNA 1, contributes to cholangiocarcinoma progression, induces angiogenesis, and disrupts vascular endothelial barriers","volume":"73","author":"Xu","year":"2021","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R119-20260512","doi-asserted-by":"crossref","first-page":"329\u201335","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"R120-20260512","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab"},{"key":"R121-20260512","doi-asserted-by":"crossref","first-page":"e12197","DOI":"10.1002\/jev2.12197","article-title":"Melanoma-derived extracellular vesicles mediate lymphatic remodelling and impair tumour immunity in draining lymph nodes","volume":"11","author":"Leary","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"R122-20260512","doi-asserted-by":"crossref","first-page":"147692","DOI":"10.1016\/j.gene.2023.147692","article-title":"Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization","volume":"885","author":"Pei","year":"2023","journal-title":"Gene"},{"key":"R123-20260512","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41419-024-06482-3","article-title":"Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"R124-20260512","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13046-023-02833-8","article-title":"Gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation","volume":"42","author":"Xie","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"R125-20260512","first-page":"4","article-title":"Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases","volume":"81","author":"Yang","journal-title":"Hepatology"},{"key":"R126-20260512","article-title":"Bile acid metabolism and signaling in liver disease","author":"Fuchs","journal-title":"J Hepatol"},{"key":"R127-20260512","doi-asserted-by":"crossref","first-page":"2005\u201318","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R128-20260512","doi-asserted-by":"crossref","first-page":"432\u201350","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R129-20260512","doi-asserted-by":"crossref","first-page":"108238","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R130-20260512","doi-asserted-by":"crossref","first-page":"315\u201327","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"R131-20260512","doi-asserted-by":"crossref","first-page":"2259\u201370","DOI":"10.1158\/0008-5472.CAN-12-2938","article-title":"HDAC6 inhibition restores ciliary expression and decreases tumor growth","volume":"73","author":"Gradilone","year":"2013","journal-title":"Cancer Res"},{"key":"R132-20260512","doi-asserted-by":"crossref","first-page":"111\u201320","DOI":"10.3109\/07357907.2012.762781","article-title":"Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway","volume":"31","author":"Dai","year":"2013","journal-title":"Cancer Invest"},{"key":"R133-20260512","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-4-41","article-title":"Impact of bile acids on the growth of human cholangiocarcinoma via FXR","volume":"4","author":"Dai","year":"2011","journal-title":"J Hematol Oncol"},{"key":"R134-20260512","doi-asserted-by":"crossref","first-page":"2317\u201326","DOI":"10.3892\/ijo.2015.2939","article-title":"Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR\/ERK1\/2 signaling pathway","volume":"46","author":"Amonyingcharoen","year":"2015","journal-title":"Int J Oncol"},{"key":"R135-20260512","doi-asserted-by":"crossref","first-page":"30988\u20131002","DOI":"10.1074\/jbc.M115.668277","article-title":"Taurocholate induces cyclooxygenase-2 expression via the sphingosine 1-phosphate receptor 2 in a human cholangiocarcinoma cell line","volume":"290","author":"Liu","year":"2015","journal-title":"J Biol Chem"},{"key":"R136-20260512","doi-asserted-by":"crossref","first-page":"1785\u201392","DOI":"10.1111\/j.1349-7006.2008.00898.x","article-title":"Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma","volume":"99","author":"Fukase","year":"2008","journal-title":"Cancer Sci"},{"key":"R137-20260512","first-page":"6500\u201305","article-title":"Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor\/Raf-1-dependent mechanism","volume":"62","author":"Yoon","year":"2002","journal-title":"Cancer Res"},{"key":"R138-20260512","doi-asserted-by":"crossref","first-page":"985\u201393","DOI":"10.1053\/gast.2002.32410","article-title":"Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line","volume":"122","author":"Yoon","year":"2002","journal-title":"Gastroenterol"},{"key":"R139-20260512","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","article-title":"Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma","volume":"43","author":"Huang","year":"2025","journal-title":"Cancer Cell"},{"key":"R140-20260512","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12866-022-02557-3","article-title":"Gallbladder microbiota composition is associated with pancreaticobiliary and gallbladder cancer prognosis","volume":"22","author":"Kirishima","year":"2022","journal-title":"BMC Microbiol"},{"key":"R141-20260512","first-page":"698","article-title":"Beyond the bile: exploring the microbiome and metabolites in cholangiocarcinoma","volume":"14","author":"Lee","year":"2024","journal-title":"Life (Basel, Switzerland)"},{"key":"R142-20260512","doi-asserted-by":"crossref","first-page":"585\u201393","DOI":"10.1097\/MEG.0000000000002948","article-title":"Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction","volume":"37","author":"Qian","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R143-20260512","doi-asserted-by":"crossref","first-page":"178.e11\u2013e22","DOI":"10.1016\/j.cmi.2015.10.008","article-title":"Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma","volume":"22","author":"Avil\u00e9s-Jim\u00e9nez","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R144-20260512","doi-asserted-by":"crossref","first-page":"327\u201334","DOI":"10.21873\/anticanres.14779","article-title":"Bile metabolites and risk of carcinogenesis in patients with pancreaticobiliary maljunction: a pilot study","volume":"41","author":"Mori","year":"2021","journal-title":"Anticancer Res"},{"key":"R145-20260512","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12876-023-03097-4","article-title":"Identification of changes in bile composition in pancreaticobiliary reflux based on liquid chromatography\/mass spectrometry metabolomics","volume":"24","author":"Da","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R146-20260512","doi-asserted-by":"crossref","first-page":"101967","DOI":"10.1016\/j.tranon.2024.101967","article-title":"Pancreatobiliary reflux increases macrophage-secreted IL-8 and activates the PI3K\/NF\u03baB pathway to promote cholangiocarcinoma progression","volume":"45","author":"Wu","year":"2024","journal-title":"Transl Oncol"},{"key":"R147-20260512","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","article-title":"Pre-metastatic niche: formation, characteristics and therapeutic implication","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"R148-20260512","doi-asserted-by":"crossref","first-page":"668\u201381","DOI":"10.1016\/j.ccell.2016.09.011","article-title":"Characteristics and significance of the pre-metastatic niche","volume":"30","author":"Liu","year":"2016","journal-title":"Cancer Cell"},{"key":"R149-20260512","doi-asserted-by":"crossref","first-page":"1774\u201388","DOI":"10.1158\/0008-5472.CAN-21-0501","article-title":"Secretion of IL1 by dedifferentiated melanoma cells inhibits JAK1-STAT3-driven actomyosin contractility of lymph node fibroblastic reticular cells","volume":"82","author":"Rovera","year":"2022","journal-title":"Cancer Res"},{"key":"R150-20260512","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41419-019-1796-6","article-title":"CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells","volume":"10","author":"Ieran\u00f2","year":"2019","journal-title":"Cell Death Dis"},{"key":"R151-20260512","doi-asserted-by":"crossref","first-page":"4882\u201394","DOI":"10.1172\/JCI73530","article-title":"Prostanoid induces premetastatic niche in regional lymph nodes","volume":"124","author":"Ogawa","year":"2014","journal-title":"J Clin Invest"},{"key":"R152-20260512","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-014-0103-8","article-title":"Blockade of CXCL12\/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway","volume":"33","author":"Zhao","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"R153-20260512","doi-asserted-by":"crossref","first-page":"196\u2013204","DOI":"10.5009\/gnl.2014.8.2.196","article-title":"Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma","volume":"8","author":"Tan","year":"2014","journal-title":"Gut Liver"},{"key":"R154-20260512","doi-asserted-by":"crossref","first-page":"541\u201357","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R155-20260512","doi-asserted-by":"crossref","first-page":"620688","DOI":"10.3389\/fonc.2021.620688","article-title":"Immunosuppressive microenvironment revealed by immune cell landscape in pre-metastatic liver of colorectal cancer","volume":"11","author":"Zeng","year":"2021","journal-title":"Front Oncol"},{"key":"R156-20260512","doi-asserted-by":"crossref","first-page":"111878","DOI":"10.1016\/j.jep.2019.111878","article-title":"Dahuang zhechong pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche","volume":"238","author":"Chen","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"R157-20260512","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41419-022-04506-4","article-title":"Cancer-derived exosomal HSPC111 promotes colorectal cancer liver metastasis by reprogramming lipid metabolism in cancer-associated fibroblasts","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R158-20260512","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/s41467-020-14869-x","article-title":"Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation","volume":"11","author":"Ji","year":"2020","journal-title":"Nat Commun"},{"key":"R159-20260512","doi-asserted-by":"crossref","first-page":"816\u201326","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"key":"R160-20260512","doi-asserted-by":"crossref","first-page":"e12186","DOI":"10.1002\/jev2.12186","article-title":"Highly-metastatic colorectal cancer cell released miR-181a-5p-rich extracellular vesicles promote liver metastasis by activating hepatic stellate cells and remodelling the tumour microenvironment","volume":"11","author":"Zhao","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"R161-20260512","doi-asserted-by":"crossref","first-page":"LBA490","DOI":"10.1200\/JCO.2023.41.4_suppl.LBA490","article-title":"SWOG 1815: a phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers","volume":"41","author":"Shroff","year":"2023","journal-title":"J Clin Oncol"},{"key":"R162-20260512","doi-asserted-by":"crossref","first-page":"690\u2013701","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"key":"R163-20260512","doi-asserted-by":"crossref","first-page":"692\u201399","DOI":"10.1001\/jamaoncol.2023.0016","article-title":"Treatment with liposomal irinotecan plus fluorouracil and leucovorin for patients with previously treated metastatic biliary tract cancer: the phase 2b NIFTY randomized clinical trial","volume":"9","author":"Hyung","year":"2023","journal-title":"JAMA Oncol"},{"key":"R164-20260512","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1016\/j.annonc.2023.09.1387","article-title":"94MO advanced extrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, \u221202 and \u221203 clinical trials","volume":"34","author":"Lamarca","year":"2023","journal-title":"Ann Oncol"},{"key":"R165-20260512","first-page":"102\u201310","article-title":"Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA)","volume":"30","author":"Ioka","year":"2023","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"key":"R166-20260512","doi-asserted-by":"crossref","first-page":"3094\u2013104","DOI":"10.1200\/JCO.23.01566","article-title":"Nanoliposomal irinotecan with fluorouracil and leucovorin or gemcitabine plus cisplatin in advanced cholangiocarcinoma: a phase II study of the AIO hepatobiliary-YMO cancer groups (NIFE-AIO-YMO HEP-0315)","volume":"42","author":"Ettrich","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R167-20260512","doi-asserted-by":"crossref","first-page":"262\u201371","DOI":"10.1200\/JCO.21.00679","article-title":"Modified FOLFIRINOX versus CISGEM chemotherapy for patients with advanced biliary tract cancer (PRODIGE 38 AMEBICA): a randomized phase II study","volume":"40","author":"Phelip","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R168-20260512","doi-asserted-by":"crossref","first-page":"63\u201369","DOI":"10.4143\/crt.2013.45.1.63","article-title":"ERCC1 can be a prognostic factor in hilar cholangiocarcinoma and extrahepatic bile duct cancer, but not in intrahepatic cholangiocarcinoma","volume":"45","author":"Park","year":"2013","journal-title":"Cancer Res Treat"},{"key":"R169-20260512","doi-asserted-by":"crossref","first-page":"2397\u2013402","DOI":"10.1002\/hep.26762","article-title":"Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting","volume":"59","author":"Sirica","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R170-20260512","doi-asserted-by":"crossref","first-page":"115323","DOI":"10.1016\/j.bcp.2022.115323","article-title":"Cisplatin in cancer treatment","volume":"206","author":"Romani","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"R171-20260512","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.3390\/ijms21144919","article-title":"Irinotecan-Still an important player in cancer chemotherapy: a comprehensive overview","volume":"21","author":"Kciuk","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R172-20260512","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/molecules30132707","article-title":"Hybrid molecules with purine and pyrimidine derivatives for antitumor therapy: news, perspectives, and future directions","volume":"30","author":"Iacob Ciobotaru","year":"2025","journal-title":"Molecules (Basel, Switzerland)"},{"key":"R173-20260512","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1016\/j.annonc.2024.08.064","article-title":"55P Subsequent anticancer therapy (SAT) analysis from 3-year follow-up of the phase III TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in biliary tract cancer (BTC)","volume":"35","author":"Vogel","year":"2024","journal-title":"Ann Oncol"},{"key":"R174-20260512","doi-asserted-by":"crossref","first-page":"4093\u2013","DOI":"10.1200\/JCO.2024.42.16_suppl.4093","article-title":"Three-year follow-up data from KEYNOTE-966: pembrolizumab (pembro) plus gemcitabine and cisplatin (gem\/cis) compared with gem\/cis alone for patients (pts) with advanced biliary tract cancer (BTC)","volume":"42","author":"Finn","year":"2024","journal-title":"J Clin Oncol"},{"key":"R175-20260512","doi-asserted-by":"crossref","first-page":"S1467","DOI":"10.1016\/j.annonc.2022.10.122","article-title":"86P outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study","volume":"33","author":"He","year":"2022","journal-title":"Ann Oncol"},{"key":"R176-20260512","doi-asserted-by":"crossref","first-page":"1853\u201365","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet (London, England)"},{"key":"R177-20260512","article-title":"Atezolizumab plus chemotherapy with or without bevacizumab in advanced biliary tract cancer: clinical and biomarker data from the randomized phase II IMbrave151 trial","author":"Macarulla","journal-title":"J Clin Oncol"},{"key":"R178-20260512","doi-asserted-by":"crossref","first-page":"103488","DOI":"10.1016\/j.esmoop.2024.103488","article-title":"An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202","volume":"9","author":"Vogel","year":"2024","journal-title":"ESMO Open"},{"key":"R179-20260512","doi-asserted-by":"crossref","first-page":"56\u201365","DOI":"10.1016\/S2468-1253(22)00335-1","article-title":"Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14)","volume":"8","author":"Lee","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R180-20260512","doi-asserted-by":"crossref","first-page":"796\u2013807","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"key":"R181-20260512","doi-asserted-by":"crossref","first-page":"1103\u201312","DOI":"10.1038\/s41591-023-02321-8","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","volume":"29","author":"Subbiah","year":"2023","journal-title":"Nature Med"},{"key":"R182-20260512","doi-asserted-by":"crossref","first-page":"228\u201339","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"New Engl J Med"},{"key":"R183-20260512","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-024-01558-1","article-title":"Targeting FGFR for cancer therapy","volume":"17","author":"Zhang","year":"2024","journal-title":"J Hematol Oncol"},{"key":"R184-20260512","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41419-025-07821-8","article-title":"FGFR inhibitors promote the autophagic degradation of IFN-\u03b3-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer","volume":"16","author":"Lin","year":"2025","journal-title":"Cell Death Dis"},{"key":"R185-20260512","doi-asserted-by":"crossref","first-page":"1519\u201329","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite d-2HG alters T cell metabolism to impair CD8(+) T cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science (New York, NY)"},{"key":"R186-20260512","doi-asserted-by":"crossref","first-page":"920\u201338","DOI":"10.1016\/j.ccell.2022.08.011","article-title":"Clinical application of advanced multi-omics tumor profiling: shaping precision oncology of the future","volume":"40","author":"Akhoundova","year":"2022","journal-title":"Cancer Cell"},{"key":"R187-20260512","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41392-024-01814-3","article-title":"Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring","volume":"9","author":"Wen","year":"2024","journal-title":"Signal Transduction Targeted Ther"},{"key":"R188-20260512","doi-asserted-by":"crossref","first-page":"1616064","DOI":"10.3389\/fcell.2025.1616064","article-title":"Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Develop Biol"},{"key":"R189-20260512","doi-asserted-by":"crossref","first-page":"25\u201342","DOI":"10.1038\/s41568-022-00527-5","article-title":"Intravital imaging to study cancer progression and metastasis","volume":"23","author":"Entenberg","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"R190-20260512","article-title":"Characterization of a syngeneic orthotopic model of cholangiocarcinoma by [(18)F]FDG-PET\/MRI","author":"Zachhuber","journal-title":"Cancers (Basel)"},{"key":"R191-20260512","doi-asserted-by":"crossref","first-page":"473\u201382","DOI":"10.1038\/s41586-025-09183-9","article-title":"Mouse liver assembloids model periportal architecture and biliary fibrosis","volume":"644","author":"Dowbaj","year":"2025","journal-title":"Nature"},{"key":"R192-20260512","doi-asserted-by":"crossref","first-page":"665\u201372","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"R193-20260512","doi-asserted-by":"crossref","first-page":"538\u201343","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"R194-20260512","doi-asserted-by":"crossref","first-page":"102627","DOI":"10.1016\/j.ctrv.2023.102627","article-title":"Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocar-cinoma","volume":"121","author":"Lamarca","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"R195-20260512","doi-asserted-by":"crossref","first-page":"878\u201385","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nature Med"},{"key":"R196-20260512","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41392-023-01317-7","article-title":"Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study","volume":"8","author":"Shi","year":"2023","journal-title":"Signal Transduction Targeted Ther"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:20:27Z","timestamp":1778581227000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":193,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003852","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"2025-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}